Yantacaw Capital
Venture fund · from SEC filings

Medtech Convergence Fund, L.P.

SV Health Investors · adviser of record: SV Life Sciences Advisers, LLC · 2018 vintage

Medtech Convergence Fund, L.P. is a 2018 venture fund managed by SV Health Investors, with $94mm raised (Form D, amount sold). It reported $80.2mm in gross assets at year-end 2025, 0.85x its size, against a peak of $90.1mm in 2022.

Latest value held
$80.2mm year-end 2025
Peak
$90.1mm year-end 2022
Fund size
$94mm Form D, amount sold
Held vs. size
0.85x peak 0.96x

Value held by year-end

$20mm$40mm$60mm$80mm$100mm20182019202020212022202320242025

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2025$80.2mm0.85x+151% over 2 yrs
2023$31.9mm0.34x-65%
2022$90.1mm0.96x+1%
2021$89.1mm0.95x+5%
2020$84.6mm0.90x+511%
2019$13.8mm0.15x–
2018$0k0.00x–

Other funds from SV Health Investors

All SV Health Investors funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-2332087528. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.